19th Nov 2012 17:26
United Drug plc
Director/PDMR Shareholding
Further to an announcement issued by United Drug plc (the 'Company') on 19 November 2009, the Company announces that restrictions on the 26,994 Ordinary Shares of €0.05 each in the Company, awarded to Mr. Chris Corbin under the Share Incentive Scheme, have today been removed and that such shares have been released from trust. The 26,994 shares were sold by Mr. C. Corbin upon vesting, details of which are provided below.
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
1 | Name of the Issuer
UNITED DRUG PLC
| 2 | Name of person discharging managerial responsibilities
MR. CHRIS CORBIN
|
3 | State whether notification relates to a person closely associated with a person discharging managerial responsibilities named in 2 and identify the connected person
N/A | 4 | Indicate whether the notification is in respect of a holding of the person referred to in 2 or 3 above or in respect of a non-beneficial interest
RELATES TO PERSON NAMED IN 2
|
5 | Description of shares or derivatives or other financial instruments linked to them
ORDINARY SHARES OF €0.05 EACH
| 6 | Name of registered shareholder(s) and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder
MR. CHRIS CORBIN |
7 | State the nature of the transaction
DISPOSAL OF ORDINARY SHARES OF €0.05 EACH
| 8 | Number of shares, derivatives or other financial instruments linked to them acquired
N/A |
9 | Number of shares, derivatives or other financial instruments linked to them disposed of
26,994 | 10 | Price per share or derivative or other financial instrument linked to them or value of transaction
£2.33 PER ORDINARY SHARE
|
11 | Date and place of transaction
19 NOVEMBER 2012 LSE | 12 | Date issuer informed of transaction
19 NOVEMBER 2012
|
13 | Any additional information
N/A | 14 | Name of contact and telephone number for queries
KAREN GEOGHEGAN + 353 1 463 7720 |
Name and signature of duly designated officer of issuer responsible for making notification
Karen Geoghegan____________________
Date of notification 19 November 2012___ | |||
The following additional information is also disclosed by the issuer.
The issuer is not required to submit the following information to the Central Bank of Ireland.
15 | Description of class of share
ORDINARY SHARES
| 16 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
N/A
|
17 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
0.01%
| 18 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
1,862,681 (0.7%) |
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
19 | Date of grant
N/A
| 20 | Period during which or date on which it can be exercised
N/A
|
21 | Total amount paid (if any) for grant of the option
N/A
| 22 | Description of shares involved (class and number)
N/A
|
23 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise
N/A
| 24 | Total number of shares over which options are held following notification
N/A
|
Related Shares:
UDG.L